Live Breaking News & Updates on தேசிய பல்கலைக்கழகம் புற்றுநோய் நிறுவனம்

Stay updated with breaking news from தேசிய பல்கலைக்கழகம் புற்றுநோய் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Singapore studies role of oral HCQ & throat spray in reducing COVID-19 spread

Drug used for cancer 'topotecan' may treat covid-19, say Singapore experts | Singapore


Wednesday, 07 Apr 2021 05:59 PM MYT
In pre-clinical tests, the team reported that the chemotherapeutic drug, Topotecan, reduces the morbidity and mortality of SARS-CoV-2 infection. Picture courtesy of Savushkin / Istock.com
Subscribe to our Telegram channel for the latest updates on news you need to know.
SINGAPORE, April 7 An international research collaboration involving researchers from Singapore and the United States has found that a widely available and inexpensive drug used for cancer treatment could potentially be used in the treatment of Covid-19.
In pre-clinical tests, the team reported that the chemotherapeutic drug, Topotecan, reduces the morbidity and mortality of SARS-CoV-2 infection by inhibiting the expression of inflammatory genes in the lungs of laboratory models of Covid-19. ....

United States , Tamil Nadu , Savushkin Istock , Jessica Sook Yuin , Anand Jeyasekharan , Research Medical Oncology , Department Of Haematology , National Research Foundation , National University Cancer Institute , Icahn School Of Medicine At Mount Sinai , Christian Medical College In Vellore , Research Fund , Icahn School Of Medicine , Icahn School , Mount Sinai , Assistant Director , Medical Oncology , Singapore Ministry , National Medical Research Council , Christian Medical College , ஒன்றுபட்டது மாநிலங்களில் , தமிழ் நாடு , ஜெசிகா அதனால் சரி யூய்ன் , ஆனந்த் ஜெயசேகரன் , ஆராய்ச்சி மருத்துவ புற்றுநோயியல் , துறை ஆஃப் ஹீமாட்டாலஜி ,

Anti-cancer drug can treat Covid-19, Singapore-US study shows


SINGAPORE - A drug used in cancer treatment can treat patients with moderate to severe forms of Covid-19, according to a study by Singapore and US researchers.
They found that Topotecan, which is used in chemotherapy, reduced the severity and death rates of infection by Sars-Cov-2 - the virus causing Covid-19 - by suppressing inflammation in the lungs of laboratory animals.
Patients with moderate to severe forms of Covid-19 suffer from inflammation, a result of an overactive, abnormal immune response. In some patients, an exaggerated immune response - typically occurring in the lungs - can flood the infected area with white blood cells, resulting in severe inflammation, tissue damage and often death. ....

United States , Anand Jeyasekharan , National Research Foundation , National University Cancer Institute , Icahn School Of Medicine At Mount Sinai , Department Of Haematology , Icahn School , Mount Sinai , Singapore Ministry , National Medical Research Council , National Research , ஒன்றுபட்டது மாநிலங்களில் , ஆனந்த் ஜெயசேகரன் , தேசிய ஆராய்ச்சி அடித்தளம் , தேசிய பல்கலைக்கழகம் புற்றுநோய் நிறுவனம் , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , துறை ஆஃப் ஹீமாட்டாலஜி , இக்ஹ்ன் பள்ளி , ஏற்ற சினை , சிங்கப்பூர் அமைச்சகம் , தேசிய மருத்துவ ஆராய்ச்சி சபை , தேசிய ஆராய்ச்சி ,

Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study


Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study
Toggle share menu
Advertisement
Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study
Dr Anand Jeyasekharan with a vial of Topotecan, a cancer drug that could potentially be used in the treatment of COVID-19. (Photo: National University Cancer Institute, Singapore)
07 Apr 2021 09:50PM)
Share this content
Bookmark
SINGAPORE: A widely available and inexpensive drug used for cancer treatment could potentially be used in the treatment of COVID-19, according to a study by Singapore and US researchers. 
They found that the chemotherapeutic drug, called Topotecan, reduced the severity and death rates of infection by the virus that causes COVID-19, by suppressing inflammation in the lungs of laboratory animals. ....

United States , Hong Kong , United Kingdom , Anand Jeyasekharan , Ivan Marazzi , National Research Foundation , National University Cancer Institute , Icahn School Of Medicine At Mount Sinai , Department Of Haematology , Research Fund , Microbiology Department , Icahn School , Mount Sinai , Singapore Ministry , National Medical Research Council , Medical Oncology , Professor Ivan Marazzi , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , ஒன்றுபட்டது கிஂக்டம் , ஆனந்த் ஜெயசேகரன் , இவன் மராஸி , தேசிய ஆராய்ச்சி அடித்தளம் , தேசிய பல்கலைக்கழகம் புற்றுநோய் நிறுவனம் , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , துறை ஆஃப் ஹீமாட்டாலஜி ,

Anti-cancer drug can treat Covid-19, Singapore-US study shows